Ironwood Pharmaceuticals
Cambridge, US · Delaware corporation · 6 known investors
Find your way into Ironwood Pharmaceuticals
55 people in our graph share verified history with the Ironwood Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
John McKearnunlockedknows Mark G. Currie · together at Searle (overlapped)
×7knows the team · via Antag Therapeutics
×2knows the team · via University of South Alabama
knows the team · via Cyclerion Therapeutics
knows the team · via Wake Forest University School of Medicine
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.
Founders & leadership
PM
PETER M. HECHTinFounder
MG
HE
HALLEY E. GIBLERTExecutive
TG
THOMAS GRANEYExecutive
TA
THOMAS A. MCCOURTinExecutive
Board
TG
LS
LAWRENCE S. OLANOFFBoard director
EP
EDWARD P. OWENSBoard director
JM
JULIE MCHUGHBoard director
MH
MARSHA H. FANUCCIBoard director
DE
DOUGLAS E. WILLIAMSBoard director
CT
CHRISTOPHER T. WALSHBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$150M disclosed across 1 round · 2016
▶$150MraisedOct 2016 · 2 investors · PharmaceuticalsRule 506(b)
▶$150MraisedOct 2016 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- LAWRENCE S. OLANOFFDirector
- TERRANCE G. MCGUIREDirector
- MARK G. CURRIEExecutive Officer
- EDWARD P. OWENSDirector
- JULIE MCHUGHDirector
- HALLEY E. GIBLERTExecutive Officer
- PETER M. HECHTExecutive Officer, Director
- MARSHA H. FANUCCIDirector
- THOMAS GRANEYExecutive Officer
- DOUGLAS E. WILLIAMSDirector
- CHRISTOPHER T. WALSHDirector
- THOMAS A. MCCOURTExecutive Officer
- ANDREW DREYFUSDirector
- Offering amount
- $150M
- Amount sold
- $150M
- Sales commissions
- $20K
- Finders' fees
- $20K
- Placement agents
- J. WOOD CAPITAL ADVISORS
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Ironwood Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Ironwood Pharmaceuticals (Nasdaq: IRWD) boosts 2026 guidance after strong Q2stocktitan.net · Aug 2026
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - BioSpacebiospace.com · Aug 2026Frequently asked questions
- What does Ironwood Pharmaceuticals do?
- Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.
- Who founded Ironwood Pharmaceuticals?
- Ironwood Pharmaceuticals was founded by PETER M. HECHT.
- Who are Ironwood Pharmaceuticals's investors?
- Ironwood Pharmaceuticals's investors include F-Prime Capital, Mountain Group Capital, Ridgeback Capital, Venrock, Maverick Ventures, Polaris Partners.
- How much funding has Ironwood Pharmaceuticals raised?
- Ironwood Pharmaceuticals has disclosed $150M raised across 1 round.
- Where is Ironwood Pharmaceuticals headquartered?
- Ironwood Pharmaceuticals is headquartered in Cambridge, US.